{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:13:42Z","timestamp":1786997622491,"version":"build-2736575974"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T00:00:00Z","timestamp":1731196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.toxrep.2024.101810","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:01:21Z","timestamp":1731672081000},"page":"101810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Molecular docking and in silico analysis of the pharmacokinetics, toxicological profile and differential gene expression of bioactive compounds from Cyrtopodium glutiniferum"],"prefix":"10.1016","volume":"13","author":[{"given":"Nat\u00e1lia Gon\u00e7alves Ribeiro","family":"Araujo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Carlos","family":"da Silva Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizandra Vit\u00f3ria de Souza","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Regina","family":"Batistuzzo de Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Felzenszwalb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Fernando","family":"Ara\u00fajo-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2024.101810_bib1","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.drudis.2008.07.004","article-title":"Natural products in drug discovery","volume":"13","author":"Harvey","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.toxrep.2024.101810_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/13102818.2020.1749527","article-title":"Medicinal plants with anti-mutagenic potential","volume":"34","author":"Akram","year":"2020","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"10.1016\/j.toxrep.2024.101810_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.toxrep.2024.101810_bib4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/acs.jcim.9b00826","article-title":"Plant metabolite databases: from herbal medicines to modern drug discovery","volume":"60","author":"Nguyen-Vo","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.toxrep.2024.101810_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201700172","article-title":"Acqua, Bioactive secondary metabolites from orchids (Orchidaceae)","volume":"14","author":"Sut","year":"2017","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.toxrep.2024.101810_bib6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jep.2014.05.006","article-title":"Chemical composition, potential toxicity, and quality control procedures of the crude drug of cyrtopodium macrobulbon","volume":"154","author":"Morales-S\u00e1nchez","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.toxrep.2024.101810_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules21101418","article-title":"Chemical constituents from the aerial parts of cyrtopodium paniculatum","volume":"21","author":"Auberon","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.toxrep.2024.101810_bib8","series-title":"Orchids as Aphrodisiac, Medicine Or Food","first-page":"159","author":"Teoh","year":"2019"},{"key":"10.1016\/j.toxrep.2024.101810_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.carbpol.2005.11.038","article-title":"Chemical properties and biological activity of a polysaccharide from cyrtopodium cardiochilum","volume":"64","author":"Barreto","year":"2006","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.toxrep.2024.101810_bib10","first-page":"1","article-title":"Cyrtopodium glutiniferum, an example of orchid used in folk medicine: phytochemical and biological aspects","author":"Araujo-Lima","year":"2021","journal-title":": Orchid. Phytochem. Biol. Hortic."},{"key":"10.1016\/j.toxrep.2024.101810_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112607","article-title":"Metabolomic analysis of cyrtopodium glutiniferum extract by UHPLC-MS\/MS and in vitro antiproliferative and genotoxicity assessment","volume":"253","author":"Ara\u00fajo-Lima","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.toxrep.2024.101810_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13530-020-00056-4","article-title":"In silico prediction of toxicity and its applications for chemicals at work","volume":"12","author":"Rim","year":"2020","journal-title":"Toxicol. Environ. Health Sci."},{"key":"10.1016\/j.toxrep.2024.101810_bib13","first-page":"724","article-title":"Recent advances in ligand-based drug design: relevance and utility","volume":"144","author":"Badal\u00e0","year":"2008","journal-title":"Comput. (Long. Beach Calif.)"},{"key":"10.1016\/j.toxrep.2024.101810_bib14","first-page":"1","author":"Gini","year":"2022","journal-title":"QSAR methods"},{"key":"10.1016\/j.toxrep.2024.101810_bib15","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1002\/ptr.7076","article-title":"A comprehensive review of the therapeutic potential of \u03b1-arbutin","volume":"35","author":"Saeedi","year":"2021","journal-title":"Phyther. Res."},{"key":"10.1016\/j.toxrep.2024.101810_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox10071129","article-title":"Arbutin as a skin depigmenting agent with antimelanogenic and antioxidant properties","volume":"10","author":"Boo","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.toxrep.2024.101810_bib17","doi-asserted-by":"crossref","DOI":"10.17219\/acem\/133493","article-title":"Arbutin inhibits inflammation and apoptosis by enhancing autophagy via SIRT1","volume":"30","author":"Ma","year":"2021","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.toxrep.2024.101810_bib18","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1021\/acs.jnatprod.5b00290","article-title":"Active constituents from Drynaria fortunei rhizomes on the attenuation of A\u03b2 25\u201335 -induced axonal atrophy","volume":"78","author":"Yang","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.toxrep.2024.101810_bib19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00253-011-3310-7","article-title":"Stereospecific microbial production of isoflavanones from isoflavones and isoflavone glucosides","volume":"91","author":"Park","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.toxrep.2024.101810_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00820","article-title":"Formononetin: a review of its anticancer potentials and mechanisms","volume":"10","author":"Tay","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxrep.2024.101810_bib21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.7150\/thno.38115","article-title":"Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE -\/- mice","volume":"10","author":"Ma","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.toxrep.2024.101810_bib22","article-title":"Formononetin: biological effects and uses \u2013 A review","volume":"359","author":"Dutra","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.toxrep.2024.101810_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119229","article-title":"Bioinformatic and biochemical studies of formononetin against liver injure","volume":"272","author":"Liao","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.toxrep.2024.101810_bib24","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.3390\/molecules27248786","article-title":"Arbutin: occurrence in plants, and its potential as an anticancer agent","volume":"27","author":"Nahar","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.toxrep.2024.101810_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbrc.2021.02.006","article-title":"Molecular modeling and phenoloxidase inhibitory activity of arbutin and arbutin undecylenic acid ester","volume":"547","author":"Masyita","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxrep.2024.101810_bib26","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxrep.2024.101810_bib27","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.toxrep.2024.101810_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxrep.2024.101810_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2013.00038","article-title":"Lazar: a modular predictive toxicology framework","volume":"4","author":"Maunz","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxrep.2024.101810_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0191838","article-title":"CLC-Pred: a freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds","volume":"13","author":"Lagunin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.toxrep.2024.101810_bib31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/10629360802083871","article-title":"An evaluation of the implementation of the cramer classification scheme in the Toxtree software","volume":"19","author":"Patlewicz","year":"2008","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.toxrep.2024.101810_bib32","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/cr100222q","article-title":"Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology","volume":"111","author":"Benigni","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.toxrep.2024.101810_bib33","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/cr300206t","article-title":"Nongenotoxic carcinogenicity of chemicals: mechanisms of action and early recognition through a new set of structural alerts","volume":"113","author":"Benigni","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.toxrep.2024.101810_bib34","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/bioinformatics\/btt322","article-title":"DIGEP-Pred: Web service for in silico prediction of drug-induced gene expression profiles based on structural formula","volume":"29","author":"Lagunin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.toxrep.2024.101810_bib35","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxrep.2024.101810_bib36","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.toxrep.2024.101810_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.toxrep.2024.101810_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1101\/gad.1389306","article-title":"Target hub proteins serve as master regulators of development in yeast","volume":"20","author":"Borneman","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.toxrep.2024.101810_bib39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1371\/journal.pcbi.0030059","article-title":"The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics","volume":"3","author":"Yu","year":"2007","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.toxrep.2024.101810_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbrc.2015.11.095","article-title":"Predicting unintended effects of drugs based on off-target tissue effects","volume":"469","author":"Kim","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxrep.2024.101810_bib41","doi-asserted-by":"crossref","unstructured":"A.M.X. Rodrigues, R.K.M. Costa, R.S. Machado, S.J.C. Gutierrez, F. das C.A. Lima, A.P. de Oliveira, In-silico studies of Riparin B in the design of drugs: physicochemical, pharmacokinetic and pharmacodynamic parameters In-silico, (2020). https:\/\/doi.org\/10.1101\/2020.04.24.059626.","DOI":"10.1101\/2020.04.24.059626"},{"key":"10.1016\/j.toxrep.2024.101810_bib42","first-page":"38","article-title":"Cytochrome P450 structure, function and clinical significance: a review","volume":"19","author":"Manikandan","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.toxrep.2024.101810_bib43","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.amjcard.2004.07.080","article-title":"Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors","volume":"94","author":"Jacobson","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.toxrep.2024.101810_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1475","article-title":"In silico toxicology: from structure\u2013activity relationships towards deep learning and adverse outcome pathways","volume":"10","author":"Hemmerich","year":"2020","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.toxrep.2024.101810_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2019.100108","article-title":"Integrating in silico models for the prediction of mutagenicity (Ames test) of botanical ingredients of cosmetics","volume":"12","author":"Raitano","year":"2019","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.toxrep.2024.101810_bib46","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.1007\/s00253-018-9241-9","article-title":"Recent progress on biological production of \u03b1-arbutin","volume":"102","author":"Zhu","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.toxrep.2024.101810_bib47","first-page":"587","article-title":"Molecular genetics and targeted therapy of WNT-related human diseases (Review)","author":"Katoh","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.toxrep.2024.101810_bib48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cellsig.2017.08.008","article-title":"Complexity of the Wnt\/\u03b2\u2011catenin pathway: searching for an activation model","volume":"40","author":"Tortelote","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.toxrep.2024.101810_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-030-43085-6_8","article-title":"Wnt signaling in osteosarcoma","author":"Singla","year":"2020","journal-title":"Curr. Adv. Sci. Osteosarcoma"},{"key":"10.1016\/j.toxrep.2024.101810_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/path.2628","article-title":"Inactive Wnt\/\u03b2-catenin pathway in conventional high-grade osteosarcoma","volume":"220","author":"Cai","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.toxrep.2024.101810_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.molonc.2012.01.003","article-title":"Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy","volume":"6","author":"Tanaka","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.toxrep.2024.101810_bib52","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s13277-014-2849-1","article-title":"miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells","volume":"36","author":"Chen","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.toxrep.2024.101810_bib53","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.3892\/ol.2020.11840","article-title":"Ring box protein-1 is associated with a poor prognosis and tumor progression in esophageal cancer","volume":"20","author":"Kunishige","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.toxrep.2024.101810_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13045-023-01485-7","article-title":"Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions","volume":"16","author":"Fu","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.toxrep.2024.101810_bib55","doi-asserted-by":"crossref","first-page":"504","DOI":"10.20892\/j.issn.2095-3941.2020.0484","article-title":"Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma","volume":"19","author":"Xian","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.toxrep.2024.101810_bib56","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.18632\/aging.204163","article-title":"E3 ubiquitin ligase RBX1 drives the metastasis of triple negative breast cancer through a FBXO45-TWIST1-dependent degradation mechanism","volume":"14","author":"Shao","year":"2022","journal-title":"Aging"},{"key":"10.1016\/j.toxrep.2024.101810_bib57","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3390\/cancers11121998","article-title":"Role of damage DNA-binding protein 1 in pancreatic cancer progression and chemoresistance","volume":"11","author":"Zhang","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.toxrep.2024.101810_bib58","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/cancers11040527","article-title":"Proteasome 26S subunit, non-ATPase 3 (PSMD3) regulates breast cancer by stabilizing HER2 from degradation","volume":"11","author":"Fararjeh","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.toxrep.2024.101810_bib59","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2174\/1568026619666181210152115","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"18","author":"Sun","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.toxrep.2024.101810_bib60","article-title":"Up-down regulation of HIF-1 \u03b1 in cancer progression","volume":"798","author":"Rashid","year":"2021"},{"key":"10.1016\/j.toxrep.2024.101810_bib61","doi-asserted-by":"crossref","unstructured":"Y. Li, Y. Xu, R. Wang, W. Li, W. He, X. Luo, Y. Ye, Expression of Notch \u2013 Hif-1 a signaling pathway in liver regeneration of rats, (2020). https:\/\/doi.org\/10.1177\/0300060520943790.","DOI":"10.1177\/0300060520943790"},{"key":"10.1016\/j.toxrep.2024.101810_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrc.2016.145","article-title":"Notch as a tumour suppressor","volume":"17","author":"Nowell","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.toxrep.2024.101810_bib63","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7150\/jca.22319","article-title":"Upregulation of HES1 promotes cell proliferation and invasion in breast cancer as a prognosis marker and therapy target via the AKT pathway and EMT process","volume":"9","author":"Li","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.toxrep.2024.101810_bib64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1084\/jem.20121192","article-title":"Loss of the notch effector RBPJ promotes tumorigenesis","volume":"212","author":"Kulic","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.toxrep.2024.101810_bib65","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1093\/nar\/gkac601","article-title":"Notch-dependent and -independent functions of transcription factor RBPJ","volume":"50","author":"Friedrich","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxrep.2024.101810_bib66","first-page":"57","article-title":"SRC signaling in cancer and tumor microenvironment","author":"Caner","year":"2021","journal-title":": Tumor Micro."},{"key":"10.1016\/j.toxrep.2024.101810_bib67","doi-asserted-by":"crossref","unstructured":"M. Asaduzzaman, S. Constantinou, H. Min, J. Gallon, M.L. Poonam, S. Selina, R. Simak, S. Shousha, R.C. Coombes, E.W. Lam, Y. Hu, E. Yagu, Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer, (2017) 461\u2013474. https:\/\/doi.org\/10.1007\/s10549-017-4202-z.","DOI":"10.1007\/s10549-017-4202-z"},{"key":"10.1016\/j.toxrep.2024.101810_bib68","doi-asserted-by":"crossref","first-page":"a026534","DOI":"10.1101\/cshperspect.a026534","article-title":"Exploitation of EP300 and CREBBP lysine acetyltransferases by cancer","volume":"7","author":"Attar","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.toxrep.2024.101810_bib69","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1046\/j.1432-1327.2001.02226.x","article-title":"p300\/CBP\/p53 interaction and regulation of the p53 response","volume":"268","author":"Grossman","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxrep.2024.101810_bib70","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbadis.2014.12.014","article-title":"The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer","volume":"1852","author":"Deng","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.toxrep.2024.101810_bib71","doi-asserted-by":"crossref","unstructured":"C. Feng, Y. Wang, Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma, (2020) 1\u201318. https:\/\/doi.org\/10.12659\/MSM.926800.","DOI":"10.12659\/MSM.926800"},{"key":"10.1016\/j.toxrep.2024.101810_bib72","doi-asserted-by":"crossref","unstructured":"L. Tian, M. Chen, Q. He, Q. Yan, C. Zhai, MicroRNA \u2011 199a \u2011 5p suppresses cell proliferation, migration and invasion by targeting ITGA3 in colorectal cancer, (2020) 2307\u20132317. https:\/\/doi.org\/10.3892\/mmr.2020.11323.","DOI":"10.3892\/mmr.2020.11323"},{"key":"10.1016\/j.toxrep.2024.101810_bib73","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.2147\/CMAR.S223201","article-title":"Integrin \u03b15\/ITGA5 promotes the proliferation, migration, invasion and progression of oral squamous carcinoma By Epithelial\u2013Mesenchymal transition","volume":"11","author":"Deng","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.toxrep.2024.101810_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2021.711149","article-title":"ITGB1 drives hepatocellular carcinoma progression by modulating cell cycle process through PXN\/YWHAZ\/AKT pathways","volume":"9","author":"Xie","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.toxrep.2024.101810_bib75","doi-asserted-by":"crossref","DOI":"10.1007\/s12282-021-01242-z","article-title":"Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC)","author":"Song","year":"2021","journal-title":"Breast Cancer"},{"key":"10.1016\/j.toxrep.2024.101810_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101534","article-title":"Tissue and Cell MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells","volume":"72","author":"Shi","year":"2021","journal-title":"Tissue Cell"},{"key":"10.1016\/j.toxrep.2024.101810_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109818","article-title":"The aurora B gradient sustains kinetochore stability in anaphase","volume":"37","author":"Papini","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.toxrep.2024.101810_bib78","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.immuni.2020.04.002","article-title":"FADD and Caspase-8 regulate gut homeostasis and inflammation by controlling MLKL- and GSDMD- mediated death of intestinal epithelial cells ll article FADD and Caspase-8 regulate gut homeostasis and inflammation by controlling MLKL- and GSDMD- mediated dea","volume":"52","author":"Schwarzer","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.toxrep.2024.101810_bib79","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.immuni.2020.05.008","article-title":"Caspase-8 and FADD: where cell death and inflammation collide","volume":"52","author":"Amaral","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.toxrep.2024.101810_bib80","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/cells8060532","article-title":"HSP90 molecular chaperones, metabolic rewiring, and epigenetics: impact on tumor progression and perspective for anticancer therapy","volume":"8","author":"Condelli","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.toxrep.2024.101810_bib81","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41467-019-14259-y","article-title":"HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors","volume":"11","author":"Song","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750024001938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750024001938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T07:09:01Z","timestamp":1735283341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750024001938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":81,"alternative-id":["S2214750024001938"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2024.101810","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular docking and in silico analysis of the pharmacokinetics, toxicological profile and differential gene expression of bioactive compounds from Cyrtopodium glutiniferum","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2024.101810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101810"}}